DE69830512D1 - Heilmittel für neurodegenerative krankheiten - Google Patents
Heilmittel für neurodegenerative krankheitenInfo
- Publication number
- DE69830512D1 DE69830512D1 DE69830512T DE69830512T DE69830512D1 DE 69830512 D1 DE69830512 D1 DE 69830512D1 DE 69830512 T DE69830512 T DE 69830512T DE 69830512 T DE69830512 T DE 69830512T DE 69830512 D1 DE69830512 D1 DE 69830512D1
- Authority
- DE
- Germany
- Prior art keywords
- neurodegenerative diseases
- remedies
- disease
- medicament
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP36931397 | 1997-12-26 | ||
JP36931397 | 1997-12-26 | ||
PCT/JP1998/005757 WO1999033465A1 (en) | 1997-12-26 | 1998-12-21 | Remedy for neurodegenerative diseases___________________________ |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69830512D1 true DE69830512D1 (de) | 2005-07-14 |
DE69830512T2 DE69830512T2 (de) | 2006-03-23 |
Family
ID=18494113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69830512T Expired - Lifetime DE69830512T2 (de) | 1997-12-26 | 1998-12-21 | Medikament für neurodegenerative Erkrankungen |
Country Status (12)
Country | Link |
---|---|
US (1) | US6342515B1 (de) |
EP (1) | EP1040830B1 (de) |
JP (1) | JP3364481B2 (de) |
KR (1) | KR100508393B1 (de) |
CN (1) | CN1149084C (de) |
AT (1) | ATE297204T1 (de) |
CA (1) | CA2317044C (de) |
DE (1) | DE69830512T2 (de) |
ES (1) | ES2244103T3 (de) |
HK (1) | HK1029043A1 (de) |
PT (1) | PT1040830E (de) |
WO (1) | WO1999033465A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050260577A1 (en) * | 2000-10-09 | 2005-11-24 | Kay Double | Detection of neurodegenerative disorders |
US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
CN1320886C (zh) * | 2002-05-17 | 2007-06-13 | 杜克大学 | 安非他酮与抗惊厥药在制备治疗肥胖症的药物的用途 |
WO2004024096A2 (en) * | 2002-09-13 | 2004-03-25 | Eisai Co., Ltd. | Method of treating tremors |
US20050059718A1 (en) * | 2003-02-21 | 2005-03-17 | Hayato Miyachi | Methods of using zonisamide as an adjunctive therapy for partial seizures |
DK2316456T3 (en) | 2003-04-29 | 2017-09-11 | Orexigen Therapeutics Inc | Compositions for affecting weight loss comprising an opioid antagonist and bupropion |
US20050043704A1 (en) * | 2003-08-21 | 2005-02-24 | Eisai Co., Ltd | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050043773A1 (en) * | 2003-08-21 | 2005-02-24 | Ivan Lieberburg | Methods of improving the safety of zonisamide therapy |
US20050154033A1 (en) * | 2004-01-08 | 2005-07-14 | Eisai Co., Ltd | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154032A1 (en) * | 2004-01-08 | 2005-07-14 | Eisai Co., Ltd | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154034A1 (en) * | 2004-01-08 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154037A1 (en) * | 2004-01-09 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154035A1 (en) * | 2004-01-09 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
US20050154036A1 (en) * | 2004-01-09 | 2005-07-14 | Eisai Co., Ltd. | Methods of using zonisamide as an adjunctive therapy for partial seizures |
WO2006023702A2 (en) * | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders with setiptiline |
EP1913935A1 (de) * | 2005-01-21 | 2008-04-23 | Teva Pharmaceutical Industries Ltd | Stabile pharmazeutische Zusammensetzungen von Zonisamide und Verfahren zur deren Herstellung |
ES2344574T3 (es) * | 2005-01-21 | 2010-08-31 | Teva Pharmaceutical Industries Ltd | Formulaciones farmaceuticas estables de zonisamida y procedimientos para su preparacion. |
US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
EP3132792B1 (de) | 2005-11-22 | 2019-09-11 | Nalpropion Pharmaceuticals, Inc. | Zusammensetzung und verfahren zur erhöhung der insulinempfindlichkeit |
US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
KR101654176B1 (ko) | 2006-11-09 | 2016-09-09 | 오렉시젠 세러퓨틱스 인크. | 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형 |
KR20170077291A (ko) | 2006-11-09 | 2017-07-05 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
WO2009054543A1 (en) * | 2007-10-26 | 2009-04-30 | Eisai R & D Management Co., Ltd. | Ampa receptor antagonists and zonisamide for parkinson's disease and movement disorders |
CA2722295C (en) | 2008-04-29 | 2019-01-15 | Pharnext | Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate |
JP2011521973A (ja) | 2008-05-30 | 2011-07-28 | オレキシジェン・セラピューティクス・インコーポレーテッド | 内臓脂肪の状態を処置するための方法 |
AU2011203867B2 (en) | 2010-01-11 | 2015-12-03 | Nalpropion Pharmaceuticals Llc | Methods of providing weight loss therapy in patients with major depression |
ES2802048T3 (es) | 2012-06-06 | 2021-01-15 | Nalpropion Pharmaceuticals Llc | Composición para uso en un método para el tratamiento de sobrepeso y obesidad en pacientes con alto riesgo cardiovascular |
JP6155266B2 (ja) * | 2012-08-01 | 2017-06-28 | 大日本住友製薬株式会社 | ゾニサミドを含有する経皮吸収型製剤 |
EP2952196A4 (de) * | 2013-01-31 | 2016-08-03 | Sawai Seiyaku Kk | Mehrschichtige tablette mit telmisartan und hydrochlorothiazid |
US20180271838A1 (en) * | 2015-09-30 | 2018-09-27 | National University Corporation Nagoya University | Pharmaceutical composition for treating and/or preventing peripheral neuropathy or spinal cord injury |
WO2019038584A1 (en) | 2017-08-19 | 2019-02-28 | Ftf Pharma Private Limited | ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PREPARATION METHOD THEREOF |
EP3928771A1 (de) * | 2020-06-23 | 2021-12-29 | Laboratorios Lesvi, S.L. | Pharmazeutische zusammensetzungen von 1,2-benzisoxazol-3-methansulfonamid |
AU2021303974A1 (en) | 2020-07-07 | 2023-02-02 | Sumitomo Pharma Co., Ltd. | Benzisoxazole derivative |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
US5128354A (en) * | 1987-12-29 | 1992-07-07 | Dainippon Pharmaceutical Co., Ltd. | Agent for treating ischemic brain damage |
US5830910A (en) * | 1995-10-23 | 1998-11-03 | University Of Kentucky Research Foundation | Cytochalasins useful in providing protection against nerve cell injury associated with neurodegenerative disorders |
-
1998
- 1998-12-21 US US09/582,433 patent/US6342515B1/en not_active Expired - Fee Related
- 1998-12-21 CN CNB98812680XA patent/CN1149084C/zh not_active Expired - Fee Related
- 1998-12-21 AT AT98961430T patent/ATE297204T1/de active
- 1998-12-21 PT PT98961430T patent/PT1040830E/pt unknown
- 1998-12-21 WO PCT/JP1998/005757 patent/WO1999033465A1/ja active IP Right Grant
- 1998-12-21 KR KR10-2000-7007033A patent/KR100508393B1/ko not_active IP Right Cessation
- 1998-12-21 ES ES98961430T patent/ES2244103T3/es not_active Expired - Lifetime
- 1998-12-21 DE DE69830512T patent/DE69830512T2/de not_active Expired - Lifetime
- 1998-12-21 JP JP2000526222A patent/JP3364481B2/ja not_active Expired - Lifetime
- 1998-12-21 CA CA002317044A patent/CA2317044C/en not_active Expired - Fee Related
- 1998-12-21 EP EP98961430A patent/EP1040830B1/de not_active Expired - Lifetime
-
2000
- 2000-10-30 HK HK00106879A patent/HK1029043A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1029043A1 (en) | 2001-03-23 |
KR20010015890A (ko) | 2001-02-26 |
ES2244103T3 (es) | 2005-12-01 |
JP3364481B2 (ja) | 2003-01-08 |
WO1999033465A1 (en) | 1999-07-08 |
ATE297204T1 (de) | 2005-06-15 |
US6342515B1 (en) | 2002-01-29 |
CA2317044C (en) | 2008-02-26 |
CN1283113A (zh) | 2001-02-07 |
CN1149084C (zh) | 2004-05-12 |
DE69830512T2 (de) | 2006-03-23 |
PT1040830E (pt) | 2005-08-31 |
KR100508393B1 (ko) | 2005-08-17 |
EP1040830A4 (de) | 2002-10-23 |
CA2317044A1 (en) | 1999-07-08 |
EP1040830A1 (de) | 2000-10-04 |
EP1040830B1 (de) | 2005-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69830512D1 (de) | Heilmittel für neurodegenerative krankheiten | |
KR920019342A (ko) | 골질환 치료제 | |
KR960700742A (ko) | 아토피성질환 치료약(atopic disease remedy) | |
BG106095A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
BR0209812A (pt) | Uso de osteopontina para o tratamento e/ou a prevenção de doenças neurológicas | |
ES2136723T3 (es) | Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante. | |
PT758241E (pt) | Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses | |
IL113941A (en) | Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them | |
DE69400799D1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
BG105302A (en) | Means for improving cognition | |
FI972308A (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
FR2711140B1 (fr) | 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant. | |
ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
EP0744176A3 (de) | Arzneimittel zur Hemmung von Knochenschwund | |
AU4568400A (en) | Sphingomyelinase inhibitor | |
FR2786100B1 (fr) | Nouvelle application therapeutique de la nicergoline | |
EP0373771A3 (de) | Neue pharmazeutische Anwendungen von Cystatinen | |
GB9126874D0 (en) | Medicaments | |
BR9915292A (pt) | Associação, utilização de riluzol e composição farmacêutica. | |
DE69928685D1 (de) | Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit | |
HUP0004647A2 (hu) | Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
NZ268914A (en) | Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease | |
ES2166912T3 (es) | Composiciones, que comprenden bismuto y uno o mas agentes antimicrobianos, para el tratamiento y prevencion de trastornos gastrointestinales. | |
DE60022084D1 (de) | Kombination von lumilysergol und riluzol für die vorbeugung und/oder behandlung von motoneuronalen erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., OSAKA, JP |
|
8364 | No opposition during term of opposition |